REGN
Regeneron Pharmaceuticals, Inc. · VIE:REGN
861.20 EUR41.60 +5.08%
Regeneron Pharmaceuticals, Inc. (VIE:REGN) last traded at 861.20 EUR, up 5.08% on the day. Over the past year the stock is up 54.06%. Its 52-week range is 512.70 to 861.20. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open827.30
Day range825.80 – 861.20
52-week range512.70 – 861.20
Volume15
Average volume (10 days)2
Market cap (USD)95.51 B
P/E21.54
EPS (TTM) (USD)45.30
Dividend yield0.40%
Beta (1 year)−0.008880
Revenue (TTM) (USD)16.90 B
Employees15.41 K
Performance
+18.26%1 week
+31.36%1 month
+30.27%3 months
+43.63%6 months
+30.88%Year to date
+54.06%1 year
Technical reading
Strongly bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Regeneron Pharma Price Target Raised to $997.00/Share From $835.00 by Leerink PartnersDow Jones Newswires · 02 Nov 2026
- Leerink Partners maintains Regeneron Pharmaceuticals at Market Perform, raises price target to $997 from $835TradingView · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $812.00/Share From $756.00 by BernsteinDow Jones Newswires · 02 Nov 2026
- Bernstein maintains Regeneron Pharmaceuticals at Market Perform, raises price target to $812 from $756TradingView · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $855.00/Share From $779.00 by Morgan StanleyDow Jones Newswires · 02 Nov 2026
- Morgan Stanley maintains Regeneron Pharmaceuticals at Equal-Weight, raises price target to $855 from $779TradingView · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $913.00/Share From $810.00 by RBC CapitalDow Jones Newswires · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $982.00/Share From $780.00 by Truist SecuritiesDow Jones Newswires · 02 Nov 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.